Algorithms to identify radiotherapy intent in unresected non-metastatic non-small-cell lung cancer: an I-O Optimise analysis

dc.contributor.authorEleanor Ralphs
dc.contributor.authorC. Rault
dc.contributor.authorAlan Calleja
dc.contributor.authorM. Daumont
dc.contributor.authorJohn R. Penrod
dc.contributor.authorMatthew D. Thompson
dc.contributor.authorSue Cheeseman
dc.contributor.authorMarta Soares
dc.coverage.spatialBolivia
dc.date.accessioned2026-03-22T15:37:16Z
dc.date.available2026-03-22T15:37:16Z
dc.date.issued2024
dc.descriptionCitaciones: 1
dc.description.abstractThis study aimed to develop and evaluate the performance of algorithms for identifying radiotherapy (RT) treatment intent in real-world data from patients with non-metastatic non-small-cell lung cancer (NSCLC). Using data from IPO-Porto hospital (Portugal) and the REAL-Oncology database (England), three algorithms were developed based on available RT information (#1: RT duration, #2: RT duration and type, #3: RT dose) and tested versus reference datasets. Study results showed that all three algorithms had good overall accuracy (91-100%) for patients receiving RT plus systemic anticancer therapy (SACT) and algorithms #2 and #3 also had good accuracy (>99%) for patients receiving RT alone. These algorithms could help classify treatment intent in patients with NSCLC receiving RT with or without SACT in real-world settings where intent information is missing/incomplete.
dc.identifier.doi10.1080/14796694.2024.2363133
dc.identifier.urihttps://doi.org/10.1080/14796694.2024.2363133
dc.identifier.urihttps://andeanlibrary.org/handle/123456789/53433
dc.language.isoen
dc.publisherFuture Medicine
dc.relation.ispartofFuture Oncology
dc.sourceIQVIA (United States)
dc.subjectMedicine
dc.subjectRadiation therapy
dc.subjectLung cancer
dc.subjectOncology
dc.subjectInternal medicine
dc.subjectDuration (music)
dc.titleAlgorithms to identify radiotherapy intent in unresected non-metastatic non-small-cell lung cancer: an I-O Optimise analysis
dc.typearticle

Files